Clinical Success of Onlays Fabricated With Different Types of Resin

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-84
SponsorMersin University

About this trial

Additive manufacturing, also referred to as "3D printing" or "rapid prototyping," is defined as the process of joining materials layer by layer to create an object based on 3D model data. In this method, a digital data set is first created on a computer (computer-aided design, CAD) and then transferred to a 3D printer. The designed object is produced by printing it in successive layers.

In contrast, in subtractive manufacturing, restorations are produced by milling homogeneous blocks based on computer-designed models. Compared to subtractive manufacturing technology, additive manufacturing allows for the production of more complex, detailed, and larger structures with much less material waste and without excessive use of force.

It is thought that additive manufacturing has the potential to overcome the disadvantages of subtractive manufacturing. Over the past decade, global sales of industrial and personal 3D printers, materials, and services have increased by more than 33% annually.

Due to its success in the production of surgical guides, temporary and permanent restorations, crowns and bridges, occlusal splints, frameworks, and orthodontic appliances, this technology has attracted significant interest in the field of dentistry.

Although additive manufacturing has started to be used as an alternative to subtractive manufacturing in many applications, there is still a lack of information regarding the chemical composition, mechanical, and physical properties of printable resins. Moreover, clinical data on the use of these resins in permanent restorations are quite limited.

Therefore, the aim of this study is to clinically evaluate and monitor for one year the performance of onlay restorations fabricated with three different resins of varying compositions in endodontically treated teeth.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Molar teeth that have undergone root canal treatment

Teeth with proximal defects located above the gingival margin

Defects limited to the occlusal surface and a single adjacent surface

Presence of an occlusal defect extending over one-third of the distance between the fissure and the cusp tip and involving one or more cusps

Disqualifiers

Fractured or cracked teeth

Patients with temporomandibular joint disorders

Patients with bruxism (teeth grinding)

Molar teeth without an opposing tooth or fixed prosthetic restoration

Trial design

Design model

Parallel

Treatments tested in this trial

  • Saremco print resin

    Device

    The teeth were restored with Saremco print resin via Asiga Max printer according to the manufacturer's instructions.

  • Varseosmile Crownplus resin

    Device

    The teeth were restored with Varseosmile Crownplus resin via Asiga Max printer according to the manufacturer's instructions.

  • Varseosmile TriniQ resin

    Device

    The teeth were restored with Varseosmile TriniQ resin via Asiga MAx printer according to the manufacturer' instructions

Treatment groups

48 Participants
are divided into 3 treatment groups
Group A: Saremco print resinActive comparator 1 intervention
Group B: Varseosmile Crownplus resinActive comparator 1 intervention
Group C: Varseosmile TriniQ resinActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Clinical performance

The clinical evaluation of restorations bonded to teeth will be performed at baseline, at 6 months, and at 12 months using the World Dental Federation (FDI) criteria which are divided into 3 main categories as functional, biological and esthetic properties. Each property is typically scored on a 1 to 5 scale: 1. \- Clinically excellent 2. \- Clinically good 3. \- Clinically sufficient 4. \- Clinically insufficient 5. \- Clinically poor

Time frame
Baseline- 6 months-12 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.